Mundipharma GmbH
4 products tracked · names used in filings: Mundipharma GmbH, Mundipharma Corporation (Ireland) Limited
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Rezzayo rezafungin | Authorised | 2023-12-22 |
| 🇪🇺 | Cegfila (previously Pegfilgrastim Mundipharma) pegfilgrastim | Authorised | 2019-12-19 |
| 🇪🇺 | Pelmeg pegfilgrastim | Authorised | 2018-11-20 |
| 🇪🇺 | Nyxoid naloxone | Authorised | 2017-11-09 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.